BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26490866)

  • 1. Predator Stress-Induced CRF Release Causes Enduring Sensitization of Basolateral Amygdala Norepinephrine Systems that Promote PTSD-Like Startle Abnormalities.
    Rajbhandari AK; Baldo BA; Bakshi VP
    J Neurosci; 2015 Oct; 35(42):14270-85. PubMed ID: 26490866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated norepinephrine receptor stimulation in the BNST induces sensorimotor gating deficits via corticotropin releasing factor.
    Rajbhandari AK; Bakshi VP
    Neuropharmacology; 2020 Aug; 172():108090. PubMed ID: 32360378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?
    Bakshi VP; Alsene KM; Roseboom PH; Connors EE
    Neuropharmacology; 2012 Feb; 62(2):737-48. PubMed ID: 21288473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity.
    Gresack JE; Risbrough VB
    Int J Neuropsychopharmacol; 2011 Oct; 14(9):1179-94. PubMed ID: 21205416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating.
    Flandreau E; Risbrough V; Lu A; Ableitner M; Geyer MA; Holsboer F; Deussing JM
    Psychoneuroendocrinology; 2015 Mar; 53():16-28. PubMed ID: 25575243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event.
    Aisenberg N; Serova L; Sabban EL; Akirav I
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):913-927. PubMed ID: 28663121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of CRF/CRFR1 signaling in the basolateral nucleus of the amygdala contributes to chronic forced swim-induced depressive-like behaviors in rats.
    Chen L; Li S; Cai J; Wei TJ; Liu LY; Zhao HY; Liu BH; Jing HB; Jin ZR; Liu M; Wan Y; Xing GG
    Behav Brain Res; 2018 Feb; 338():134-142. PubMed ID: 29080675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of NPY Y
    Michaelson SD; Miranda Tapia AP; McKinty A; Silveira Villarroel H; Mackay JP; Urban JH; Colmers WF
    J Neurosci; 2020 Apr; 40(16):3231-3249. PubMed ID: 32144180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
    Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
    Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD.
    Adamec R; Fougere D; Risbrough V
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):747-57. PubMed ID: 19751543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.
    Alsene KM; Rajbhandari AK; Ramaker MJ; Bakshi VP
    Neuropsychopharmacology; 2011 Apr; 36(5):1003-14. PubMed ID: 21248721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.
    Park PE; Vendruscolo LF; Schlosburg JE; Edwards S; Schulteis G; Koob GF
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1867-75. PubMed ID: 23590881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
    Conti LH
    Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation.
    Roozendaal B; Schelling G; McGaugh JL
    J Neurosci; 2008 Jun; 28(26):6642-51. PubMed ID: 18579737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.
    Sutherland JE; Burian LC; Covault J; Conti LH
    Pharmacol Biochem Behav; 2010 Dec; 97(2):227-38. PubMed ID: 20709096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
    Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
    J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex.
    Liang KC; Melia KR; Campeau S; Falls WA; Miserendino MJ; Davis M
    J Neurosci; 1992 Jun; 12(6):2313-20. PubMed ID: 1607942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basolateral amygdala corticotropin-releasing factor receptor type 1 regulates context-cocaine memory strength during reconsolidation in a sex-dependent manner.
    Ritchie JL; Walters JL; Galliou JMC; Christian RJ; Qi S; Savenkova MI; Ibarra CK; Grogan SR; Fuchs RA
    Neuropharmacology; 2021 Dec; 200():108819. PubMed ID: 34610289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological stimulation of locus coeruleus reveals a new antipsychotic-responsive pathway for deficient sensorimotor gating.
    Alsene KM; Bakshi VP
    Neuropsychopharmacology; 2011 Jul; 36(8):1656-67. PubMed ID: 21508929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.